Chevelle Clarke
Jan 13, 2024
Introducing the first and only one-dose canine parvovirus treatment.
Canine parvovirus, or parvo, is one of the most common causes of illness and death in dogs worldwide. While vaccination can help prevent canine parvovirus, there have been no antiviral treatment options for dogs who become infected — until now. Canine Parvovirus Monoclonal Antibody (CPMA) is the first and only USDA-conditionally approved, one-dose canine parvovirus treatment. The (CPMA) is a new antibody that is offered in the aid of mild to moderate canine parvovirus cases.
One dose
With just one intravenous dose, CPMA may shorten the course of the disease and improve the outcome.
Proven effective
A study of infected dogs who were treated with CPMA showed significantly faster resolution of symptoms including vomiting, lethargy and lack of appetite.
Well tolerated in puppies as young as 6 weeks of age
In a safety study of 147 healthy dogs who received CPMA, CPMA was well tolerated. If a reaction occurred, it was generally mild and recovered within one day.
May help dogs get home sooner
Use of CPMA may help decrease hospitalization time for canine parvovirus.
Think your dog might have canine parvovirus? Treatment can’t wait!
Canine parvovirus is a highly contagious disease that destroys the intestinal lining. It can be fatal if not treated quickly. Puppies are at high risk for canine parvovirus until they have been fully vaccinated, and unvaccinated dogs are also at risk. If you notice any of the following signs, call your veterinarian immediately and ask about canine parvovirus and CPMA as a potential treatment.
Lack of appetite
Vomiting
Hemorrhagic diarrhea
Abdominal pain
Lethargy
Fever
If you have any questions or concerns about a possible canine parvovirus case do not hesitate to call your local Veterinarian Clinic or The Family Pet Clinic of Phelan at (760) 868-8620.